Tylenol-Maker Kenvue Shares Bounce, Trump Claims Face Pushback

Reuters

Sep 23

Sept 23 (Reuters) - Tylenol-maker Kenvue KVUE.N stock rose in European trading on Tuesday, even after U.S. President Donald Trump linked its popular pain medication to autism risk during pregnancy.

Kenvue's shares gained 6% in premarket, rebounding from a record low hit the previous day ahead of Trump's extraordinary White House press conference.

Citi analysts said they expected the stock to recover, citing the absence of new scientific evidence.

"Overall, we see limited judicial risk following today's announcement, but there could be some impact on Tylenol consumption due to negative headlines," they wrote.

Many doctors reject the claim, and Kenvue reiterated there is no scientific link between acetaminophen, the active ingredient in Tylenol, and autism, warning that such suggestions could endanger maternal health.

The Food and Drug Administration said it will update labels on Tylenol and generic versions to reflect evidence of a possible link between acetaminophen use during pregnancy and neurological conditions such as autism and ADHD, but stressed that no causal relationship has been established.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2569760554"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2569760554\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2569760554?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-23 16:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2569760554","market":"us","top_or_hot":-1,"title":"Tylenol-Maker Kenvue Shares Bounce, Trump Claims Face Pushback","media":"Reuters","content":"<html><head></head><body><p>Sept 23 (Reuters) - Tylenol-maker Kenvue KVUE.N stock rose in European trading on Tuesday, even after U.S. President Donald Trump linked its popular pain medication to autism risk during pregnancy.</p><p>Kenvue&#39;s shares gained 6% in premarket, rebounding from a record low hit the previous day ahead of Trump&#39;s extraordinary White House press conference.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/9bea4a79721a62526ba6bb9a9fc82c9d\" tg-width=\"852\" tg-height=\"827\"/></p><p>Citi analysts said they expected the stock to recover, citing the absence of new scientific evidence.</p><p>&#34;Overall, we see limited judicial risk following today&#39;s announcement, but there could be some impact on Tylenol consumption due to negative headlines,&#34; they wrote.</p><p>Many doctors reject the claim, and Kenvue reiterated there is no scientific link between acetaminophen, the active ingredient in Tylenol, and autism, warning that such suggestions could endanger maternal health.</p><p>The Food and Drug Administration said it will update labels on Tylenol and generic versions to reflect evidence of a possible link between acetaminophen use during pregnancy and neurological conditions such as autism and ADHD, but stressed that no causal relationship has been established.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tylenol-Maker Kenvue Shares Bounce, Trump Claims Face Pushback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTylenol-Maker Kenvue Shares Bounce, Trump Claims Face Pushback\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-23 16:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Sept 23 (Reuters) - Tylenol-maker Kenvue KVUE.N stock rose in European trading on Tuesday, even after U.S. President Donald Trump linked its popular pain medication to autism risk during pregnancy.</p><p>Kenvue&#39;s shares gained 6% in premarket, rebounding from a record low hit the previous day ahead of Trump&#39;s extraordinary White House press conference.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/9bea4a79721a62526ba6bb9a9fc82c9d\" tg-width=\"852\" tg-height=\"827\"/></p><p>Citi analysts said they expected the stock to recover, citing the absence of new scientific evidence.</p><p>&#34;Overall, we see limited judicial risk following today&#39;s announcement, but there could be some impact on Tylenol consumption due to negative headlines,&#34; they wrote.</p><p>Many doctors reject the claim, and Kenvue reiterated there is no scientific link between acetaminophen, the active ingredient in Tylenol, and autism, warning that such suggestions could endanger maternal health.</p><p>The Food and Drug Administration said it will update labels on Tylenol and generic versions to reflect evidence of a possible link between acetaminophen use during pregnancy and neurological conditions such as autism and ADHD, but stressed that no causal relationship has been established.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BFXG1179.USD","symbol_name":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nL5N3VA0AA:1","article_id":"2569760554","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2569760554","pubTimestamp":1758615825,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Tylenol-maker Kenvue shares bounce, Trump claims face pushback Sept 23 (Reuters) - Tylenol-maker Kenvue KVUE.N stock rose in European trading on Tuesday, even after U.S. President Donald Trump linked ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4183":"个人用品","LU0128525929.USD":"TEMPLETON GLOBAL \"A\" (USD) ACC","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","LU0310800379.SGD":"FTIF - Templeton Global A Acc SGD","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","LU1267930573.SGD":"TEMPLETON GLOBAL \"AA\" (SGD) ACC A","LU0029864427.USD":"TEMPLETON GLOBAL \"A\" (USD) INC","KVUE":"Kenvue Inc","LU0708994859.HKD":"TEMPLETON GLOBAL \"A\" (HKD) ACC","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","BK4588":"碎股","BK4585":"ETF&股票定投概念"},"translate_title":"泰诺制造商Kenvue股价反弹，特朗普声称面临阻力","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KVUE":0.9},"content_text":"Sept 23 (Reuters) - Tylenol-maker Kenvue KVUE.N stock rose in European trading on Tuesday, even after U.S. President Donald Trump linked its popular pain medication to autism risk during pregnancy.Kenvue's shares gained 6% in premarket, rebounding from a record low hit the previous day ahead of Trump's extraordinary White House press conference.Citi analysts said they expected the stock to recover, citing the absence of new scientific evidence.\"Overall, we see limited judicial risk following today's announcement, but there could be some impact on Tylenol consumption due to negative headlines,\" they wrote.Many doctors reject the claim, and Kenvue reiterated there is no scientific link between acetaminophen, the active ingredient in Tylenol, and autism, warning that such suggestions could endanger maternal health.The Food and Drug Administration said it will update labels on Tylenol and generic versions to reflect evidence of a possible link between acetaminophen use during pregnancy and neurological conditions such as autism and ADHD, but stressed that no causal relationship has been established.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}